<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cocera-Ortega L</submitter><funding>DCVA ARENA-PRIME Young Talent program</funding><funding>Netherlands Organisation for Health Research and Development</funding><pagination>4053</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9000197</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(7)</volume><pubmed_abstract>Long-QT syndrome type 1 (LQT1) is caused by mutations in &lt;i>KCNQ1&lt;/i>. Patients heterozygous for such a mutation co-assemble both mutant and wild-type &lt;i>KCNQ1&lt;/i>-encoded subunits into tetrameric Kv7.1 potassium channels. Here, we investigated whether allele-specific inhibition of mutant &lt;i>KCNQ1&lt;/i> by targeting a common variant can shift the balance towards increased incorporation of the wild-type allele to alleviate the disease in human-induced pluripotent stem-cell-derived cardiomyocytes (hiPSC-CMs). We identified the single nucleotide polymorphisms (SNP) rs1057128 (G/A) in &lt;i>KCNQ1&lt;/i>, with a heterozygosity of 27% in the European population. Next, we determined allele-specificity of short-hairpin RNAs (shRNAs) targeting either allele of this SNP in hiPSC-CMs that carry an LQT1 mutat</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>shRNAs Targeting a Common &lt;i>KCNQ1&lt;/i> Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele.</pubmed_title><pmcid>PMC9000197</pmcid><funding_grant_id>VENI 91616150</funding_grant_id><funding_grant_id>-</funding_grant_id><pubmed_authors>Tijsen AJ</pubmed_authors><pubmed_authors>de Vries DK</pubmed_authors><pubmed_authors>Gepstein L</pubmed_authors><pubmed_authors>Pinto YM</pubmed_authors><pubmed_authors>Kamps SC</pubmed_authors><pubmed_authors>Verkerk AO</pubmed_authors><pubmed_authors>Huber I</pubmed_authors><pubmed_authors>Wilders R</pubmed_authors><pubmed_authors>Cocera-Ortega L</pubmed_authors><pubmed_authors>van den Bout A</pubmed_authors><pubmed_authors>Fabrizi B</pubmed_authors><pubmed_authors>van der Made I</pubmed_authors></additional><is_claimable>false</is_claimable><name>shRNAs Targeting a Common &lt;i>KCNQ1&lt;/i> Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele.</name><description>Long-QT syndrome type 1 (LQT1) is caused by mutations in &lt;i>KCNQ1&lt;/i>. Patients heterozygous for such a mutation co-assemble both mutant and wild-type &lt;i>KCNQ1&lt;/i>-encoded subunits into tetrameric Kv7.1 potassium channels. Here, we investigated whether allele-specific inhibition of mutant &lt;i>KCNQ1&lt;/i> by targeting a common variant can shift the balance towards increased incorporation of the wild-type allele to alleviate the disease in human-induced pluripotent stem-cell-derived cardiomyocytes (hiPSC-CMs). We identified the single nucleotide polymorphisms (SNP) rs1057128 (G/A) in &lt;i>KCNQ1&lt;/i>, with a heterozygosity of 27% in the European population. Next, we determined allele-specificity of short-hairpin RNAs (shRNAs) targeting either allele of this SNP in hiPSC-CMs that carry an LQT1 mutat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-04-08T10:36:04.853Z</modification><creation>2025-02-19T01:10:59.497Z</creation></dates><accession>S-EPMC9000197</accession><cross_references><pubmed>35409410</pubmed><doi>10.3390/ijms23074053</doi></cross_references></HashMap>